FIELD: pharmaceuticals.
SUBSTANCE: invention refers to compounds of formula I, where R1 and R2 are specified in the patent claim, their pharmaceutically acceptable salts and pharmaceutical compositions containing said compounds.
(I)
EFFECT: said compounds and pharmaceutical compositions containing them can be used for treating or preventing mGluR5-mediated disorders, such as acute and/or chronic neurological disorders, cognitive impairment and memory impairment, as well as acute and chronic pain.
23 cl, 1 tbl, 11 ex
Title | Year | Author | Number |
---|---|---|---|
CONDENSED DERIVATIVES OF IMIDAZOLE AND PYRAZOLE AS MODULATORS OF ACTIVITY TNF | 2014 |
|
RU2686117C1 |
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2786722C1 |
NITRILE-CONTAINING ANTIVIRAL COMPOUNDS | 2021 |
|
RU2820150C2 |
CONDENSED TRICYCLIC BENZIMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2689777C1 |
FUSED TRICYCLIC IMIDAZOLE DERIVATIVES AS MODULATORS OF TNF ACTIVITY | 2014 |
|
RU2679914C9 |
ANTIPROLIFERATIVE AGENTS FOR THE TREATMENT OF PAH | 2020 |
|
RU2786588C1 |
METHOD FOR PREPARING 6-ALKYLIDENEPENEM DERIVATIVES | 2003 |
|
RU2317297C2 |
MACROCYCLIC COMPOUNDS AS TRK KINASE INHIBITORS | 2019 |
|
RU2778294C2 |
NEW DERIVATIVES OF AMINOPYRIDINE AS ANTAGONISTS mGIuR5 | 2004 |
|
RU2330020C2 |
TREATMENT METHOD | 2012 |
|
RU2621148C2 |
Authors
Dates
2020-12-30—Published
2016-10-21—Filed